What's new

Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 6, Status: Authorised

May 6, 2025 - 16:05
 0
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Report: Scout's Range Extending Gas Engines Will Be Built In Mexico

Next Article

List of medicines currently in PRIME scheme

Related Posts

EU Implementation Guide (IG) on veterinary medicines pr...

Apr 26, 2025  0

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Summary of opinion: Xofluza, 25/04/2025 Positive

Summary of opinion: Xofluza, 25/04/2025 Positive

Apr 28, 2025  0